Continuing Education Event – Moms on Maintenance: Best Practices for Medication for Addiction Treatment (MAT) in Pregnancy – webinar – 9/8/2021
Pregnancy is a time when women with substance use disorders (SUDs) are often highly motivated for recovery so their growing fetus can be born a healthy baby. However, achieving meaningful recovery in pregnancy can be tricky. Visibly pregnant women are subject to even more stigma than the general population of people with SUDs. This stigma is present when they are seen smoking, drinking alcohol, or using drugs as well as when they are accepting treatment! In addition, many women have had negative experiences with child protective services which leads them to fear the impact of maintenance treatment sometimes more than the consequences of ongoing substance use. This training will focus on the evidence related to treating nicotine, alcohol, and opioid use disorders in pregnancy. There will also be discussion of how child protective services legislation and personal autonomy play a role in a woman’s decision to accept gold standard MAT during pregnancy.
1. Describe evidence-based treatment options for NUD, AUD, and OUD during pregnancy.
2. Explain why maintenance medication for OUD during pregnancy is preferable to medically-supervised withdrawal.
3. Provide a framework for collaboration with child protective services that supports moms choosing evidence-based care for their SUDs.
4. Explore the concept of personal autonomy and harm reduction when gold-standard treatment is not chosen.
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 2 credit hours.
Dr. Heidi Ginter, MD, FASAM has nearly two decades of experience working in the addiction treatment field, is Board Certified in Addiction Medicine, and is a prominent voice in medication-assisted treatment (MAT). MAT, the use of FDA-approved medications in combination with counseling and behavioral therapies, is widely considered to be an effective tool in battling addiction to opioids and other drugs.
Dr. Ginter graduated from Yale University and earned her doctorate at the University of Maryland School of Medicine. She has lectured extensively on MAT and opioid dependence. Dr. Ginter started her career as a family doctor for underserved populations and eventually found a passion for helping pregnant women struggling with addiction. Most recently, she was the Regional Medical Director and Chief Medical Officer for an outpatient addiction treatment provider with 16 sites in Massachusetts, Maine, New Hampshire and Connecticut.